FRANKFURT, Oct 1 (Reuters) – German biotech Morphosys
moved a step closer to getting its first antibody drug
onto the market as its licensee, Johnson & Johnson unit
Jenssen, reported positive…
The post Morphosys moves closer to getting first antibody drug on market appeared first on NASDAQ.